These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26655277)

  • 1. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.
    de Aguiar RB; Parise CB; Souza CR; Braggion C; Quintilio W; Moro AM; Navarro Marques FL; Buchpiguel CA; Chammas R; de Moraes JZ
    Cancer Lett; 2016 Feb; 371(2):151-60. PubMed ID: 26655277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis.
    Xiao L; Yang S; Hao J; Yuan X; Luo W; Jiang L; Hu Y; Fu Z; Zhang Y; Zou C
    Cancer Lett; 2015 Apr; 359(1):148-54. PubMed ID: 25597785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
    Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
    Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivo.
    Kretzschmann VK; Gellrich D; Ullrich A; Zahler S; Vollmar AM; Kazmaier U; Fürst R
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):294-303. PubMed ID: 24285578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
    Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
    Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.
    Liekens S; Noppen S; Gijsbers S; Sienaert R; Ronca R; Tobia C; Presta M
    Oncotarget; 2015 Mar; 6(7):4633-48. PubMed ID: 25609197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies targeting basic fibroblast growth factor inhibit the growth of B16 melanoma in vivo and in vitro.
    Li D; Wang H; Xiang JJ; Deng N; Wang PP; Kang YL; Tao J; Xu M
    Oncol Rep; 2010 Aug; 24(2):457-63. PubMed ID: 20596633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Inhibitory Effect of Propylene Glycol Alginate Sodium Sulfate on Fibroblast Growth Factor 2-Mediated Angiogenesis and Invasion in Murine Melanoma B16-F10 Cells In Vitro.
    Ma H; Qiu P; Xu H; Xu X; Xin M; Chu Y; Guan H; Li C; Yang J
    Mar Drugs; 2019 Apr; 17(5):. PubMed ID: 31035725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Cells Require CD98 for Efficient Angiogenesis-Brief Report.
    Liao Z; Cantor JM
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2163-2166. PubMed ID: 27687603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
    Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
    Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.
    Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N
    Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
    Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
    Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
    Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
    Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
    Sheu JR; Fu CC; Tsai ML; Chung WJ
    Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma.
    Yang JH; Hu J; Wan L; Chen LJ
    Asian Pac J Cancer Prev; 2014; 15(1):167-74. PubMed ID: 24528020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo.
    Yu Y; Gao S; Li Q; Wang C; Lai X; Chen X; Wang R; Di J; Li T; Wang W; Wu X
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1321-8. PubMed ID: 22481251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
    Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
    Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erlotinib and bevacizumab have synergistic activity against melanoma.
    Schicher N; Paulitschke V; Swoboda A; Kunstfeld R; Loewe R; Pilarski P; Pehamberger H; Hoeller C
    Clin Cancer Res; 2009 May; 15(10):3495-502. PubMed ID: 19447871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.